| Primary |
| Psoriasis |
50.6% |
| Product Used For Unknown Indication |
14.1% |
| Crohn's Disease |
12.7% |
| Psoriatic Arthropathy |
11.0% |
| Prophylaxis |
1.6% |
| Sarcoidosis |
1.5% |
| Ill-defined Disorder |
1.3% |
| Hypertension |
1.3% |
| Pustular Psoriasis |
0.7% |
| Liver Disorder |
0.6% |
| Anxiety |
0.5% |
| Contraception |
0.5% |
| Pain |
0.5% |
| Diarrhoea |
0.5% |
| Depression |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Nausea |
0.4% |
| Arthritis |
0.4% |
| Medical Diet |
0.4% |
| Prophylaxis Against Graft Versus Host Disease |
0.4% |
|
| Pneumonia |
11.2% |
| Cerebrovascular Accident |
7.1% |
| Prostate Cancer |
7.1% |
| Psoriasis |
6.7% |
| Anal Abscess |
5.6% |
| Cellulitis |
5.6% |
| Liver Function Test Abnormal |
5.6% |
| Drug Ineffective |
5.2% |
| Myocardial Infarction |
5.2% |
| Breast Cancer |
4.1% |
| Colon Cancer |
4.1% |
| Pustular Psoriasis |
4.1% |
| Squamous Cell Carcinoma |
4.1% |
| Renal Failure Acute |
3.7% |
| Urinary Tract Infection |
3.7% |
| Hypertension |
3.4% |
| Malignant Melanoma |
3.4% |
| Pyrexia |
3.4% |
| Syncope |
3.4% |
| Upper Respiratory Tract Infection |
3.4% |
|
| Secondary |
| Psoriasis |
59.9% |
| Crohn's Disease |
14.2% |
| Psoriatic Arthropathy |
9.8% |
| Product Used For Unknown Indication |
3.1% |
| Prophylaxis |
3.0% |
| Arthritis |
2.1% |
| Hypertension |
1.3% |
| Sarcoidosis |
1.0% |
| Transient Ischaemic Attack |
0.7% |
| Anxiety |
0.6% |
| Bronchitis |
0.5% |
| Pustular Psoriasis |
0.5% |
| Radiculopathy |
0.5% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Contraception |
0.4% |
| Diabetes Mellitus |
0.4% |
| Diarrhoea |
0.4% |
| Liver Disorder |
0.4% |
| Nausea |
0.4% |
| Pain |
0.4% |
|
| Prostate Cancer |
18.5% |
| Oesophageal Spasm |
10.2% |
| Oesophageal Carcinoma |
7.6% |
| Testis Cancer |
7.6% |
| Wound Dehiscence |
7.1% |
| Colon Cancer |
6.9% |
| Asthma |
4.0% |
| Malignant Melanoma In Situ |
4.0% |
| Pneumonia |
4.0% |
| Anal Abscess |
3.6% |
| Postoperative Wound Infection |
3.3% |
| Cerebrovascular Accident |
3.1% |
| Pyrexia |
2.9% |
| Liver Function Test Abnormal |
2.7% |
| Pancreatitis Acute |
2.5% |
| Urinary Tract Infection |
2.5% |
| Myocardial Infarction |
2.4% |
| Psoriasis |
2.4% |
| Respiratory Failure |
2.4% |
| Wound Infection |
2.4% |
|
| Concomitant |
| Psoriasis |
44.7% |
| Product Used For Unknown Indication |
17.1% |
| Crohn's Disease |
15.8% |
| Arrhythmia |
5.3% |
| Hypercholesterolaemia |
2.6% |
| Hypertension |
2.6% |
| Psoriatic Arthropathy |
2.6% |
| Abscess Limb |
1.3% |
| Anticoagulant Therapy |
1.3% |
| Erythrodermic Psoriasis |
1.3% |
| Insomnia |
1.3% |
| Medical Diet |
1.3% |
| Skin Irritation |
1.3% |
| Weight Decreased |
1.3% |
|
| Cervical Dysplasia |
10.5% |
| Cervix Carcinoma Stage 0 |
10.5% |
| Osteoarthritis |
10.5% |
| Cerebrovascular Accident |
5.3% |
| Depression |
5.3% |
| Disease Progression |
5.3% |
| Drug Ineffective |
5.3% |
| Endocarditis |
5.3% |
| Epithelioid Sarcoma |
5.3% |
| Hypersensitivity Vasculitis |
5.3% |
| Listeriosis |
5.3% |
| Myocardial Infarction |
5.3% |
| Peripheral T-cell Lymphoma Unspecified Stage Iv |
5.3% |
| Skin Reaction |
5.3% |
| Tinea Pedis |
5.3% |
| Vomiting |
5.3% |
|
| Interacting |
|
| Erythema Multiforme |
100.0% |
|
